Literature DB >> 30694354

[Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].

Nora Woltsche1, Laila El-Shabrawi-Caelen2, Teresa Deinlein2, Romana Kupsa2, Martha Gschwandtner3, Rainer Hofmann-Wellenhof2, Iris Zalaudek4.   

Abstract

Eruptive epidermoid cysts are a rare adverse event of imiquimod treatment for basal cell carcinoma. Up to date, 8 cases have been described in the literature. We present the case of a 75-year-old Caucasian woman with recurrent basal cell carcinoma on the nose. After multiple excisions and treatment with vismodegib, imiquimod 5% cream was administered 5 times per week over 6 weeks. Two months after the end of treatment, the patient presented with eruptive epidermoid cysts.

Entities:  

Keywords:  Adverse event; Excision; Immunomodulators; Infundibular cysts; Skin cancer

Mesh：

Substances：

Year:  2019        PMID： 30694354     DOI： 10.1007/s00105-019-4359-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  10 in total

1.  Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.

Authors:  Danica Tiodorovic-Zivkovic; Iris Zalaudek; Caterina Longo; Barbara De Pace; Giuseppe Albertini; Giuseppe Argenziano
Journal:  Eur J Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.328

2.  Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod.

Authors:  Maria Rita Nasca; Rocco De Pasquale; Giuseppe Micali
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

3.  Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.

Authors:  Alessandra Drummond; Janine Pichler; Giuseppe Argenziano; Iris Zalaudek; Caterina Longo; Aimilios Lallas; Simonetta Piana; Elvira Moscarella
Journal:  Australas J Dermatol       Date:  2014-02-13       Impact factor: 2.875

Review 4.  Imiquimod in dermatology: an overview.

Authors:  Edith Hanna; Rami Abadi; Ossama Abbas
Journal:  Int J Dermatol       Date:  2016-08       Impact factor: 2.736

5.  Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study.

Authors:  Marta Urech; Athanassios Kyrgidis; Giuseppe Argenziano; Camilla Reggiani; Elvira Moscarella; Caterina Longo; Roberto Alfano; Iris Zalaudek; Aimilios Lallas
Journal:  Acta Derm Venereol       Date:  2017-01-04       Impact factor: 4.437

6.  [Eruptive epidermoid cysts during topical imiquimod treatment].

Authors:  A-S Dillies; V Gras-Champel; S Fraitag-Spinner; F Al Saïf; E Carmi
Journal:  Ann Dermatol Venereol       Date:  2016-10-17       Impact factor: 0.777

7.  Treatment of epidermal cysts with erbium: YAG laser fenestration: an alternative to surgical intervention.

Authors:  Chin-Jung Feng; Hsu Ma
Journal:  Ann Plast Surg       Date:  2015-05       Impact factor: 1.539

8.  Eruptive epidermoid cysts resulting from treatment with imiquimod.

Authors:  Chelsy L Marty; Henry W Randle; John S Walsh
Journal:  Dermatol Surg       Date:  2005-07       Impact factor: 3.398

9.  Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.

Authors:  Laura Diluvio; Elena Campione; Evelin Jasmine Paternò; Augusto Orlandi; Alessandro Terrinoni; Sergio Chimenti
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

10.  Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression.

Authors:  Nicole Amberg; Martin Holcmann; Gabriel Stulnig; Maria Sibilia
Journal:  J Invest Dermatol       Date:  2016-07-01       Impact factor: 8.551
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.